FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907231618> ?p ?o ?g. }

• W2907231618 endingPage "4768" @default.
• W2907231618 startingPage "4768" @default.
• W2907231618 abstract "Abstract Background: HCT is physically and psychologically challenging and patients are prone to QoL impairments. AYAs are a unique population that faces hurdles due to dynamic changes in several aspects of their life, and may be particularly prone to QoL issues during HCT. The aim of this study was to determine if QoL differences exist between AYA and older adult HCT recipients pre- and post-HCT. Additionally, we aimed to determine if there has been a change in QoL for AYA transplant recipients in recent years, as more focus has been placed on supporting this unique population. Methods: QoL data were collected prospectively pre-HCT (baseline [BL]) and in follow-up post-transplant on patients undergoing HCT from Jun 2003 through Dec 2017 at Cleveland Clinic. Autologous HCT recipients are followed routinely through day +42 post-transplant, while allogeneic recipients are followed through at least one year or more. QoL was self-reported by patients using the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation (FACT-BMT) questionnaire. FACT-BMT consists of five domain scores (Physical Wellbeing [PWB], Social Wellbeing [SWB], Emotional Wellbeing [EWB], Functional Wellbeing [FWB], and Additional Concerns [AC]) and two summary scores (trial outcome index [TOI, PWB+FWB+AC], and Total FACT Score. Scores were compared for younger AYA (age 15-29 years), older AYA (age 30-39 years) and older adults (age 40-60 years). We excluded patients >60 years from analysis as this group may have their own unique challenges. Repeated measures analysis of variance was used to assess differences among age groups and among time points. Pearson correlation (r) was used to determine if BL QOL had improved from 2003-2017 in AYA cohort. Separate analyses were performed for autologous and allogeneic cohorts. Results: Autologous HCT cohort included 128 AYA patients (56 younger AYA) and 355 older adults, and allogeneic HCT cohort included 136 AYA patients (76 younger AYA) and 295 older adults Autologous patients in all three groups were similar for baseline characteristics except for diagnosis (table 1). Among allogeneic patients similar rates of graft-versus host disease were seen for all three groups, and baseline characteristics were similar except for ECOG performance status (table 1). Among autologous recipients, no single QoL domain or composite score differed among the three age groups at baseline or at day +42 post-HCT (Figure 1a). In all age groups, QoL improved from baseline to D+42 in autologous HCT recipients (mean Total Score 149 vs. 152, p=0.001). Similarly, among the allogeneic HCT recipients, no single QoL domain or composite score differed among the three age groups at baseline, day +100, +180, or +365 post-HCT (Figure 1b). Among all patients compared to BL (mean 146), total FACT score improved at day +180 (150, p=0.022) and +365 (152, p=0.005), but not at day 100 (145, p=0.57). Among autologous recipients, none of the BL FACT domains improved over time since 2003. In contrast, AYA allogeneic recipients also had no significant change in BL scores since 2003 for PWB, SWB, EWB, FWB, however there was improvement in AC (r=0.26, p=0.003, TOI (r=0.23, p=0.008), and total FACT score (r=0.19, p=0.03). Conclusions: AYA HCT recipients do not have inferior QoL compared to older adults in the first 42 days after autologous HCT and the first year after allogeneic HCT. Interestingly, QoL improvements in AYA patients have occurred in recent years for allogeneic but not autologous patients. Improvements in QoL of allogeneic patients is driven by the AC domain, which addresses multiple psychosocial aspects which have been emphasized in recent years. Continued efforts to tailor treatment and support for AYA HSCT recipients is critical to improving outcomes. Disclosures Advani: Glycomimetics: Consultancy; Novartis: Consultancy; Amgen: Research Funding; Pfizer: Honoraria, Research Funding. Majhail:Atara: Honoraria; Anthem, Inc.: Consultancy; Incyte: Honoraria." @default.
• W2907231618 created "2019-01-11" @default.
• W2907231618 creator A5000495553 @default.
• W2907231618 creator A5007885407 @default.
• W2907231618 creator A5011655907 @default.
• W2907231618 creator A5011922168 @default.
• W2907231618 creator A5019494133 @default.
• W2907231618 creator A5042594365 @default.
• W2907231618 creator A5043043292 @default.
• W2907231618 creator A5044158881 @default.
• W2907231618 creator A5045738764 @default.
• W2907231618 creator A5046052708 @default.
• W2907231618 creator A5047116338 @default.
• W2907231618 creator A5049744314 @default.
• W2907231618 creator A5050880000 @default.
• W2907231618 creator A5082944296 @default.
• W2907231618 creator A5089111761 @default.
• W2907231618 date "2018-11-29" @default.
• W2907231618 modified "2023-09-26" @default.
• W2907231618 title "Adolescent and Young Adult (AYA) Hematopoietic Cell Transplantation (HCT) Recipients Have Similar Quality of Life (QoL) Compared to Older Adults in the First Year Post-Transplantation" @default.
• W2907231618 doi "https://doi.org/10.1182/blood-2018-99-113027" @default.
• W2907231618 hasPublicationYear "2018" @default.
• W2907231618 type Work @default.
• W2907231618 sameAs 2907231618 @default.
• W2907231618 citedByCount "1" @default.
• W2907231618 countsByYear W29072316182023 @default.
• W2907231618 crossrefType "journal-article" @default.
• W2907231618 hasAuthorship W2907231618A5000495553 @default.
• W2907231618 hasAuthorship W2907231618A5007885407 @default.
• W2907231618 hasAuthorship W2907231618A5011655907 @default.
• W2907231618 hasAuthorship W2907231618A5011922168 @default.
• W2907231618 hasAuthorship W2907231618A5019494133 @default.
• W2907231618 hasAuthorship W2907231618A5042594365 @default.
• W2907231618 hasAuthorship W2907231618A5043043292 @default.
• W2907231618 hasAuthorship W2907231618A5044158881 @default.
• W2907231618 hasAuthorship W2907231618A5045738764 @default.
• W2907231618 hasAuthorship W2907231618A5046052708 @default.
• W2907231618 hasAuthorship W2907231618A5047116338 @default.
• W2907231618 hasAuthorship W2907231618A5049744314 @default.
• W2907231618 hasAuthorship W2907231618A5050880000 @default.
• W2907231618 hasAuthorship W2907231618A5082944296 @default.
• W2907231618 hasAuthorship W2907231618A5089111761 @default.
• W2907231618 hasBestOaLocation W29072316181 @default.
• W2907231618 hasConcept C109159458 @default.
• W2907231618 hasConcept C126322002 @default.
• W2907231618 hasConcept C159110408 @default.
• W2907231618 hasConcept C1862650 @default.
• W2907231618 hasConcept C187212893 @default.
• W2907231618 hasConcept C205545832 @default.
• W2907231618 hasConcept C2779951463 @default.
• W2907231618 hasConcept C28328180 @default.
• W2907231618 hasConcept C2908647359 @default.
• W2907231618 hasConcept C2911091166 @default.
• W2907231618 hasConcept C2993713153 @default.
• W2907231618 hasConcept C535046627 @default.
• W2907231618 hasConcept C54355233 @default.
• W2907231618 hasConcept C71924100 @default.
• W2907231618 hasConcept C74909509 @default.
• W2907231618 hasConcept C86803240 @default.
• W2907231618 hasConcept C99454951 @default.
• W2907231618 hasConceptScore W2907231618C109159458 @default.
• W2907231618 hasConceptScore W2907231618C126322002 @default.
• W2907231618 hasConceptScore W2907231618C159110408 @default.
• W2907231618 hasConceptScore W2907231618C1862650 @default.
• W2907231618 hasConceptScore W2907231618C187212893 @default.
• W2907231618 hasConceptScore W2907231618C205545832 @default.
• W2907231618 hasConceptScore W2907231618C2779951463 @default.
• W2907231618 hasConceptScore W2907231618C28328180 @default.
• W2907231618 hasConceptScore W2907231618C2908647359 @default.
• W2907231618 hasConceptScore W2907231618C2911091166 @default.
• W2907231618 hasConceptScore W2907231618C2993713153 @default.
• W2907231618 hasConceptScore W2907231618C535046627 @default.
• W2907231618 hasConceptScore W2907231618C54355233 @default.
• W2907231618 hasConceptScore W2907231618C71924100 @default.
• W2907231618 hasConceptScore W2907231618C74909509 @default.
• W2907231618 hasConceptScore W2907231618C86803240 @default.
• W2907231618 hasConceptScore W2907231618C99454951 @default.
• W2907231618 hasIssue "Supplement 1" @default.
• W2907231618 hasLocation W29072316181 @default.
• W2907231618 hasOpenAccess W2907231618 @default.
• W2907231618 hasPrimaryLocation W29072316181 @default.
• W2907231618 hasRelatedWork W1984054899 @default.
• W2907231618 hasRelatedWork W2084505320 @default.
• W2907231618 hasRelatedWork W2088891312 @default.
• W2907231618 hasRelatedWork W2280878786 @default.
• W2907231618 hasRelatedWork W2352080890 @default.
• W2907231618 hasRelatedWork W2410491650 @default.
• W2907231618 hasRelatedWork W2604682584 @default.
• W2907231618 hasRelatedWork W2752094163 @default.
• W2907231618 hasRelatedWork W2907231618 @default.
• W2907231618 hasRelatedWork W3199083754 @default.
• W2907231618 hasVolume "132" @default.
• W2907231618 isParatext "false" @default.
• W2907231618 isRetracted "false" @default.
• W2907231618 magId "2907231618" @default.
• W2907231618 workType "article" @default.